Literature DB >> 8757342

Altered T cell ligands derived from a major house dust mite allergen enhance IFN-gamma but not IL-4 production by human CD4+ T cells.

D C Tsitoura1, A Verhoef, C M Gelder, R E O'Hehir, J R Lamb.   

Abstract

Changes in the affinity of the interaction between T cell Ag receptors and their ligands can modulate selected T cell effector functions. Since both allergen-specific Th2 and Th0 cells are present in the peripheral CD4+ T cell pool of atopic individuals, the potential to inhibit cytokine production by Th2 cells and promote Th1-type cytokines from Th0 cells may contribute to the down-regulation of allergic inflammation. The aim of this study was to investigate the effects of peptide analogues of a dominant T cell epitope of the group II allergen derived from house dust mite, residues 28 to 40, on proliferation and cytokine production by human Th2 and Th0 cells. From both functional competition and proliferation assays, using analogues substituted with alanine or charged amino acids, the influence of different positions in p28-40 on TCR recognition and/or MHC class II binding was determined. For the specific Th0 cells, generally those analogues that lead to a reduction in proliferation also decreased both IL-4 and IFN-gamma production. However, the p28-40 analogues with alanine residues at positions 34 and 36 altered the IFN-gamma:IL-4 ratio by selectively enhancing IFN-gamma secretion. In the case of Th2 cells, stimulation with the peptide analogues induced different patterns of effector function. Selected analogues were capable of inducing IL-4 production in the absence of proliferation, whereas in response to other peptide variants of p28-40, both IL-4 production and proliferation were inhibited.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757342

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Allergen-specific CD8(+) T cells and atopic disease.

Authors:  Suranjith L Seneviratne; Louise Jones; Abigail S King; Antony Black; Sheila Powell; Andrew J McMichael; Graham S Ogg
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 2.  Immunotherapy for allergies and asthma: present and future.

Authors:  Shyam S Mohapatra; Momina Qazi; Gary Hellermann
Journal:  Curr Opin Pharmacol       Date:  2010-06-21       Impact factor: 5.547

Review 3.  T and B cell responses to HDM allergens and antigens.

Authors:  Wayne R Thomas; Belinda J Hales
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function.

Authors:  C Lekutis; N L Letvin
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Immunoproteomic analysis of house dust mite antigens reveals distinct classes of dominant T cell antigens according to function and serological reactivity.

Authors:  Carla Oseroff; Lars H Christensen; Luise Westernberg; John Pham; Jerome Lane; Sinu Paul; Jason Greenbaum; Thomas Stranzl; Gitte Lund; Ilka Hoof; Jens Holm; Peter A Würtzen; Kåre H Meno; April Frazier; Veronique Schulten; Peter S Andersen; Bjoern Peters; Alessandro Sette
Journal:  Clin Exp Allergy       Date:  2016-11-07       Impact factor: 5.018

Review 6.  Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis.

Authors:  Alan P Knutsen; Raymond G Slavin
Journal:  Clin Dev Immunol       Date:  2011-04-05

7.  Immunopathology and immunogenetics of allergic bronchopulmonary aspergillosis.

Authors:  Alan P Knutsen
Journal:  J Allergy (Cairo)       Date:  2011-09-28

8.  IL-4 alpha chain receptor (IL-4Ralpha) polymorphisms in allergic bronchopulmonary sspergillosis.

Authors:  Alan P Knutsen; Barbara Kariuki; Judy D Consolino; Manoj R Warrier
Journal:  Clin Mol Allergy       Date:  2006-02-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.